SBIR/STTR Research Award

Ultrasensitive Nonisotopic Detection of RNA

Award identifier 40d97f3026bfb05b9eb861162be63efc2144176c04d28f184b5a8c24b2535e45Awarding agency Department of Health and Human Services

Award amount

$729,903

Program and phase

SBIR · Phase II

Award year

1996

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
AMBION DIAGNOSTICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Nonisotopic calorimetric and chemiluminescent technologies will be developed for use withribonuclease protection assays. The ribonuclease protection assay is an increasingly utilized techniquein molecular biology affording sensitive and quantitative measurement of mRNA levels. The ability ofthe assay to detect multiple mRNA levels simultaneously makes this technique a unique and powerfultool for use in research and diagnostic applications. In a ribonuclease protection assay, autoradiographyof the polyacrylamide gel-resolved products represents the endpoint of the experiment. However, allof the available nonisotopic detection protocols require blotting of nucleic acids onto a sold support priorto detection. Therefor, we propose an approach which will circumvent this requirement and allowdetection directly in the gel used to resolve the nucleic acids. Our initial studies demonstrated that invitro transcripts containing 4-thiouridine are both functional in ribonuclease protection assays and canbe detected in gel down to 1 picomole by a colormetric detection protocol using N-ethylamaleimide andbase. During phase I, we will synthesize a derivative of N-ethylmaleimide which has been reported togreatly potentiate the sensitivity of thiol detection. Furthermore, in an effort to extend the sensitivityof ribonuclease protection assays beyond that attainable with radioactivity, we will synthesize a thiolatedderivative of the chemiluminescent molecule isoluminol. This derivative will be coupled to either4-thiouridine- or 5 mercuriuridine-substituted transcripts and detected using a non-enzymatic, butcatalytic, oxidation system with molecules which can all readily diffuse in and out of a polyacrylamidegel matrix. Once we have developed a nonisotopic ribonuclease protection assay, it will be utilized witha panel of oncogene and tumor suppressor gene probes which are used extensively at Ambion for thedevelopment of single base mismatch technologies. Ultimately, the technologies which we develop willhave wide applications in molecular biology research extending beyond ribonuclease protection assays.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.